Clovis Oncology says data to be presented at ASCO annual meeting

theflyonthewall.com

Clovis Oncology announced that three abstracts highlighting results from three Phase I studies of the company’s two lead compounds will be presented at the American Society of Clinical Oncology, ASCO, Annual Meeting 2013 in Chicago. Data contained in the published abstracts was current as of the submission deadline of February 5, 2013. Data to be presented in the poster sessions will include data from the trials as of early May, the company said.

View Comments